{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T20:06:46Z","timestamp":1788120406083,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T00:00:00Z","timestamp":1686355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ad.2023.01.017","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:06:20Z","timestamp":1686567980000},"page":"T631-T635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["[Translated article] Congenital and Infantile Hemangiomas: Epidemiological, Clinical, and Treatment Characteristics Based on 3 Years\u2019 Experience at a Tertiary Care Hospital \u2013 A Retrospective Case Comparison and Review of the Literature"],"prefix":"10.1016","volume":"114","author":[{"given":"F.J.","family":"Melgosa Ramos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"D\u00edaz-Corpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Santos-Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Galarreta Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Aguado V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Mateu Puchades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2023.01.017_bib0100","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.3390\/ijms23042358","article-title":"ISSVA Classification of vascular anomalies and molecular biology","volume":"23","author":"Kunimoto","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ad.2023.01.017_bib0105","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jaad.2021.08.019","article-title":"Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment","volume":"85","author":"Rodr\u00edguez Bandera","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.01.017_bib0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/DAD.0000000000000983","article-title":"Vascular tumors in infants: case report and review of clinical, histopathologic, and immunohistochemical characteristics of infantile hemangioma, pyogenic granuloma, noninvoluting congenital hemangioma, tufted angioma, and kaposiform hemangioendothelioma","volume":"40","author":"Johnson","year":"2018","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2023.01.017_bib0115","doi-asserted-by":"crossref","first-page":"e000816","DOI":"10.1136\/bmjpo-2020-000816","article-title":"Congenital haemangiomas: a single-centre retrospective review","volume":"4","author":"Braun","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.ad.2023.01.017_bib0120","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12788\/j.sder.2016.045","article-title":"Congenital hemangiomas","volume":"35","author":"Boull","year":"2016","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.ad.2023.01.017_bib0125","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaad.2021.08.020","article-title":"Infantile hemangioma. Part 2: Management","volume":"85","author":"Sebaratnam","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2023.01.017_bib0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jamadermatol.2021.0596","article-title":"Efficacy and safety of topical timolol for the treatment of infantile hemangioma in the early proliferative stage: a randomized clinical trial","volume":"157","author":"Mu\u00f1oz-Garza","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.01.017_bib0135","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJMoa1404710","article-title":"A randomized, controlled trial of oral propranolol in infantile hemangioma","volume":"372","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2023.01.017_bib0140","doi-asserted-by":"crossref","first-page":"e20173866","DOI":"10.1542\/peds.2017-3866","article-title":"Efficacy of propranolol between 6 and 12 months of age in high-risk infantile hemangioma","volume":"142","author":"Baselga","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/j.ad.2023.01.017_bib0145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamadermatol.2021.0469","article-title":"Clinical features, prognostic factors, and treatment interventions for ulceration in patients with infantile hemangioma","volume":"157","author":"Fern\u00e1ndez Faith","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.01.017_bib0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/jamadermatol.2019.3839","article-title":"Evaluating the safety of oral propranolol therapy in patients with PHACE syndrome","volume":"156","author":"Olsen","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ad.2023.01.017_bib0155","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12519-019-00327-2","article-title":"Risk factors for infantile hemangioma: a meta-analysis","volume":"16","author":"Ding","year":"2020","journal-title":"World J Pediatr"},{"key":"10.1016\/j.ad.2023.01.017_bib0160","article-title":"Interventions for infantile haemangiomas of the skin","volume":"4","author":"Novoa","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ad.2023.01.017_bib0165","first-page":"e15907","article-title":"Comparison of the efficacy and safety of lasers, topical timolol, and combination therapy for the treatment of infantile hemangioma: a meta-analysis of 10 studies","volume":"7","author":"Huang","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2023.01.017_bib0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ad.2019.03.015","article-title":"Oral atenolol for infantile hemangioma: case series of 46 infants","volume":"111","author":"Calder\u00f3n-Castrat","year":"2020","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"10.1016\/j.ad.2023.01.017_bib0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamapediatrics.2021.4565","article-title":"Noninferiority and safety of nadolol vs propranolol in infants with infantile hemangioma: a randomized clinical trial","volume":"176","author":"Pope","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.ad.2023.01.017_bib0180","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/pde.14163","article-title":"Propranolol-resistant infantile hemangioma successfully treated with sirolimus","volume":"37","author":"D\u00e1vila-Osorio","year":"2020","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ad.2023.01.017_bib0185","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ajhg.2016.03.009","article-title":"Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma","volume":"98","author":"Ayturk","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ad.2023.01.017_bib0190","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1684\/ejd.2021.4172","article-title":"Sequelae following infantile haemangiomas treated with propranolol","volume":"31","author":"Baselga","year":"2021","journal-title":"Eur J Dermatol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023004866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731023004866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:15:26Z","timestamp":1757553326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731023004866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0001731023004866"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2023.01.017","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Congenital and Infantile Hemangiomas: Epidemiological, Clinical, and Treatment Characteristics Based on 3 Years\u2019 Experience at a Tertiary Care Hospital \u2013 A Retrospective Case Comparison and Review of the Literature","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2023.01.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}